Navigation Links
Model 1575 Immunowash and MICROTECH 12-Channel Manifold from Bio-Rad

ProductsModel 1575 Immunowash and MICROTECH 12-Channel Manifold from Bio-Rad
Company Bio-Rad
Item Model 1575 Immunowash and MICROTECH 12-Channel Manifold
Price 
Description The Model 1575 immunowash microplate washer 100-240 V, is used for washing 96-well microplates that have flat-, U-, or V-bottom wells. The immunowash microplate washer has programmability of horizontal and vertical needle positions to an accuracy of 0.1 mm for bottom washing, crosswise aspiration, and overflow washing. It can store up to 75 wash sequences for customized protocols and includes a bottle and tubing set, 8-port manifold, aerosol protection cover, MICROTECH 12-channel manifold, power cord, and instructions.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Shake n Stack oven - New Model from Thermo Scientific
2. Holten Maxi Safe 2010 Cabinet Model 1.5, with divided tabletop from Thermo Scientific
3. Holten Safe 2010 Cabinet Model 0.9, with divided tabletop (230V / 50Hz) from Thermo Scientific
4. Brownlee Electrophysiology Amplifier Model 410 from AutoMate Scientific, Inc
5. Brownlee Electrophysiology Amplifier Model 440 with signal conditioner from AutoMate Scientific, Inc
6. Model 111 Mini IEF Cell, complete from Bio-Rad
7. Model 175 Tube Cell from Bio-Rad
8. Sub-Cell Model 192 and PowerPac Basic Power Supply from Bio-Rad
9. Sub-Cell Model 96 and PowerPac Basic Power Supply from Bio-Rad
10. Printer Paper for Model 680 Series Readers, 2 rolls from Bio-Rad
11. Model 1575 Immunowash Microplate Washer from Bio-Rad
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 1Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 3Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 1Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 2Innovator 26apos 3Bs Studio offers Social Media Strategy Intensive Sept 16 17 2009 53443 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5
Breaking Biology Technology:BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5